Nektar Therapeutics Stock Plunges on Earnings, Disclosure of Drug Trial Issues Barron's
from Top stories - Google News
Shares of biotech firm Nektar Therapeutics collapsed after the company revealed in an earnings call that there had been manufacturing issues in two batches of ...
View full coverage on Google Newsfrom Top stories - Google News
Nektar Therapeutics Stock Plunges on Earnings, Disclosure of Drug Trial Issues - Barron's
![Nektar Therapeutics Stock Plunges on Earnings, Disclosure of Drug Trial Issues - Barron's]()
Reviewed by Moltivie
on
August 10, 2019
Rating:
No comments: